Skip to main content

Table 2 Spearman's rank correlation coefficients between SHQ scores and other HRQOL measures and clinical variables

From: Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study

  SHQ-DF SHQ-PF SHQ-EF SHQ-Total
SF-36     
   Physical functioning 0.54 0.66 0.49 0.60
   Role-physical 0.70 0.60 0.66 0.74
   Bodily pain 0.68 0.68 0.53 0.68
   General health perceptions 0.78 0.52 0.66 0.74
   Vitality 0.77 0.54 0.70 0.77
   Social functioning 0.75 0.49 0.74 0.77
   Role-emotional 0.69 0.51 0.69 0.71
   Mental health 0.69 0.45 0.71 0.71
SGRQ     
   Symptoms -0.30 -0.48 -0.27 -0.35
   Activity -0.53 -0.71 -0.49 -0.59
   Impact -0.49 -0.60 -0.45 -0.53
   Total -0.55 -0.74 -0.51 -0.61
Radiographic stage - - - -
ACE - - - -
sIL2-R -0.24 - -0.20 -0.22
%FVC 0.18 0.27 - 0.18
%FEV1 - - - -
%DLCO - - - -
LVEF - - - -
PASP - -0.38 - -
MRC -0.44 -0.56 -0.46 -0.50
CES-D -0.65 -0.39 -0.70 -0.68
  1. Missing data (-) indicate that the relationships were not statistically significant.
  2. Abbreviations: HRQOL, health-related quality of life; DF, Daily Functioning; PF, Physical Functioning; EF, Emotional Functioning; SHQ, Sarcoidosis Health Questionnaire; SF-36, Medical Outcomes Study 36-item short form; SGRQ, St. George's Respiratory Questionnaire; ACE, angiotensin-converting enzyme; sIL-2R, soluble interleukin-2 receptor; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; DLCO, diffusion capacity for carbon monoxide; LVEF, left ventricular ejection fraction; PASP, pulmonary arterial systolic pressure; MRC, Medical Research Council; CES-D, Center for Epidemiologic Study-Depression Scale